Litcius/Paper detail

Objectively assessed physiological, physical, and cognitive function along with patient-reported outcomes during the first 2 years of Alemtuzumab treatment in multiple sclerosis: a prospective observational study

Lars G. Hvid, Egon Stenager, Ulrik Dalgas

2022Journal of Neurology14 citationsDOI

Topics & Concepts

Paced Auditory Serial Addition TestObservational studyPhysical therapyAlemtuzumabPhysical medicine and rehabilitationMultiple sclerosisMedicineCognitionTimed Up and Go testHospital Anxiety and Depression ScaleNeurologyExpanded Disability Status ScaleAnxietyRehabilitationDepression (economics)PsychologyPsychiatryCognitive impairmentInternal medicineBalance (ability)TransplantationMacroeconomicsEconomicsMultiple Sclerosis Research StudiesRheumatoid Arthritis Research and TherapiesAmyotrophic Lateral Sclerosis Research
Objectively assessed physiological, physical, and cognitive function along with patient-reported outcomes during the first 2 years of Alemtuzumab treatment in multiple sclerosis: a prospective observational study | Litcius